NASDAQ: TCBI
TEXAS CAPITAL BANCSHARES INC/TXCIK 0001077428 · SIC 6022 · State Savings Banks
Micro by revenue · Mega by assets
Revenue $149K
Assets $33.9B
as of Oct 18, 2026
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (FPS 10-K) is open in full — no account needed.
10-Q
Filed Oct 22, 2026
· Period ending Sep 30, 2026
Texas Capital Bancshares reported net income of $103.7M for the third quarter of 2026, down 1.4% from $105.2M a year earlier.
3 material changes detected. Sign up free to read the summary.
8-K
Filed Oct 21, 2026
· Period ending Oct 21, 2026
Summary not yet generated.
Partner
Trade TCBI commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
8-K
Filed Sep 16, 2026
· Period ending Sep 16, 2026
Summary not yet generated.
8-K
Filed Sep 14, 2026
· Period ending Sep 14, 2026
Summary not yet generated.
10-Q
Filed Jul 23, 2026
· Period ending Jun 30, 2026
Summary not yet generated.
8-K
Filed Jul 22, 2026
· Period ending Jul 22, 2026
Summary not yet generated.
10-Q
Filed Apr 23, 2026
· Period ending Mar 31, 2026
Summary not yet generated.
8-K
Filed Apr 23, 2026
· Period ending Apr 16, 2026
Summary not yet generated.
8-K
Filed Mar 9, 2026
· Period ending Mar 9, 2026
Summary not yet generated.
424B5
Filed Feb 26, 2026
Summary not yet generated.
424B5
Filed Feb 24, 2026
Summary not yet generated.
10-K
Filed Feb 10, 2026
· Period ending Dec 31, 2025
Summary not yet generated.
10-Q
Filed Oct 23, 2025
· Period ending Sep 30, 2025
Summary not yet generated.
10-K
Filed Feb 11, 2025
· Period ending Dec 31, 2024
Summary not yet generated.
424B5
Filed Apr 29, 2021
Summary not yet generated.
10-K/A
Filed Mar 2, 2020
· Period ending Dec 31, 2019
Summary not yet generated.
Latest financial statements
From 10-Q filed Oct 22, 2026 (period ending Sep 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Consolidated Statements of Income (Unaudited)
(in thousands except per share data)
| Description | Three months ended September 30, 2026 | Three months ended September 30, 2025 | Nine months ended September 30, 2026 | Nine months ended September 30, 2025 |
|---|---|---|---|---|
| Interest income | ||||
| Interest and fees on loans | 379,297 | 379,017 | 1,095,733 | 1,077,525 |
| Debt and equity securities | 50,927 | 49,396 | 146,824 | 141,952 |
| Interest bearing cash and cash equivalents | 26,936 | 32,202 | 73,627 | 107,994 |
| Total interest income | 457,160 | 460,615 | 1,316,184 | 1,327,471 |
| Interest expense | ||||
| Deposits | 174,517 | 180,779 | 495,448 | 530,513 |
| Short-term borrowings | 84 | 534 | 5,996 | 12,224 |
| Long-term debt | 7,576 | 7,531 | 24,661 | 23,534 |
| Total interest expense | 182,177 | 188,844 | 526,105 | 566,271 |
| Net interest income | 274,983 | 271,771 | 790,079 | 761,200 |
| Provision for credit losses | 17,000 | 12,000 | 51,000 | 44,000 |
| Net interest income after provision for credit losses | 257,983 | 259,771 | 739,079 | 717,200 |
| Non-interest income | ||||
| Service charges on deposit accounts | 9,418 | 8,111 | 27,494 | 24,133 |
| Wealth management and trust fee income | 4,562 | 3,989 | 14,086 | 11,683 |
| Brokered loan fees | 2,075 | 2,419 | 6,184 | 6,766 |
| Investment banking and advisory fees | 35,294 | 33,985 | 98,832 | 74,572 |
| Trading income | 11,417 | 7,238 | 32,981 | 21,073 |
| Available-for-sale debt securities gains/(losses) | — | — | — | (1,886) |
| Other | 18,877 | 12,841 | 46,450 | 30,755 |
| Total non-interest income | 81,643 | 68,583 | 226,027 | 167,096 |
| Non-interest expense | ||||
| Salaries and benefits | 121,625 | 119,856 | 384,311 | 371,651 |
| Occupancy expense | 13,230 | 11,828 | 37,994 | 34,816 |
| Marketing | 4,266 | 3,412 | 14,024 | 12,045 |
| Legal and professional | 12,000 | 12,474 | 38,680 | 38,532 |
| Communications and technology | 32,029 | 24,594 | 87,695 | 72,550 |
| Federal Deposit Insurance Corporation insurance assessment | 5,234 | 5,198 | 14,697 | 15,635 |
| Other | 15,540 | 13,213 | 45,584 | 38,642 |
| Total non-interest expense | 203,924 | 190,575 | 622,985 | 583,871 |
| Income before income taxes | 135,702 | 137,779 | 342,121 | 300,425 |
| Income tax expense | 31,997 | 32,569 | 79,680 | 70,840 |
| Net income | 103,705 | 105,210 | 262,441 | 229,585 |
| Preferred stock dividends | 4,313 | 4,313 | 12,938 | 12,938 |
| Net income available to common stockholders | 99,392 | 100,897 | 249,503 | 216,647 |
| Other comprehensive income | ||||
| Change in unrealized gain/(loss) | (199,835) | 30,909 | (249,538) | 101,226 |
| Amounts reclassified into net income | 2,772 | 6,172 | 7,935 | 26,498 |
| Other comprehensive income/(loss) | (197,063) | 37,081 | (241,603) | 127,724 |
| Income tax expense/(benefit) | (45,324) | 8,374 | (55,569) | 28,841 |
| Other comprehensive income/(loss), net of tax | (151,739) | 28,707 | (186,034) | 98,883 |
| Comprehensive income/(loss) | (48,034) | 133,917 | 76,407 | 328,468 |
| Basic earnings per common share | 2.30 | 2.21 | 5.72 | 4.72 |
| Diluted earnings per common share | 2.28 | 2.18 | 5.66 | 4.67 |
Consolidated Balance Sheets (Unaudited)
(in thousands except share data)
| Description | September 30, 2026 | December 31, 2025 |
|---|---|---|
| Assets | ||
| Cash and due from banks | 195,086 | 201,315 |
| Interest bearing cash and cash equivalents | 2,479,073 | 1,897,803 |
| Available-for-sale debt securities | 4,095,855 | 3,951,455 |
| Held-to-maturity debt securities | 672,881 | 725,722 |
| Equity securities | 42,007 | 41,998 |
| Trading debt securities | — | 3,924 |
| Debt and equity securities | 4,810,743 | 4,723,099 |
| Loans held for sale | 28,676 | 4,361 |
| Loans held for investment, mortgage finance | 5,441,689 | 6,064,019 |
| Loans held for investment | 18,641,301 | 17,976,183 |
| Less: Allowance for credit losses on loans | 270,333 | 270,557 |
| Loans held for investment, net | 23,812,657 | 23,769,645 |
| Premises and equipment, net | 89,012 | 88,003 |
| Accrued interest receivable and other assets | 928,364 | 854,552 |
| Goodwill and intangibles, net | 1,496 | 1,496 |
| Total assets | 32,345,107 | 31,540,274 |
| Liabilities and Stockholders’ Equity | ||
| Liabilities: | ||
| Non-interest bearing deposits | 7,006,314 | 6,959,097 |
| Interest bearing deposits | 20,709,341 | 19,489,670 |
| Total deposits | 27,715,655 | 26,448,767 |
| Accrued interest payable | 8,556 | 6,716 |
| Other liabilities | 646,036 | 502,834 |
| Short-term borrowings | — | 330,000 |
| Long-term debt | 487,270 | 620,575 |
| Total liabilities | 28,857,517 | 27,908,892 |
| Stockholders’ equity: | ||
| Preferred stock, $0.01 par value, $1,000 liquidation value: | ||
| Authorized shares - 10,000,000 | ||
| Issued shares 300,000 at September 30, 2026 and December 31, 2025 | 300,000 | 300,000 |
| Common stock, $0.01 par value: | ||
| Authorized shares - 100,000,000 | ||
| Issued shares 52,023,856 and 51,786,456 at September 30, 2026 and December 31, 2025, respectively | 520 | 518 |
| Additional paid-in capital | 1,086,246 | 1,074,496 |
| Retained earnings | 3,040,853 | 2,808,645 |
| Treasury stock 9,594,199 and 7,532,768 shares at cost at September 30, 2026 and December 31, 2025, respectively | (689,410) | (487,692) |
| Accumulated other comprehensive loss, net of taxes | (250,619) | (64,585) |
| Total stockholders’ equity | 3,487,590 | 3,631,382 |
| Total liabilities and stockholders’ equity | 32,345,107 | 31,540,274 |
Consolidated Statements of Cash Flows (Unaudited)
(in thousands)
| Description | Nine months ended September 30, 2026 | Nine months ended September 30, 2025 |
|---|---|---|
| Operating activities | ||
| Net income | 262,441 | 229,585 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Provision for credit losses | 51,000 | 44,000 |
| Depreciation and amortization | 40,068 | 36,291 |
| Net loss on available-for-sale debt securities | — | 1,886 |
| Net (gain)/loss on equity securities | (4,773) | (2,265) |
| Sales/(purchases) of trading debt securities, net | 3,924 | (2,219) |
| Loss on redemption of long-term debt | 2,157 | — |
| Stock-based compensation expense | 35,125 | 28,614 |
| Sales/(purchases) of loans held for sale, net | (2,982) | — |
| Changes in operating assets and liabilities: | ||
| Accrued interest receivable and other assets | (32,319) | (39,949) |
| Accrued interest payable and other liabilities | 43,647 | (66,283) |
| Net cash provided by operating activities | 398,288 | 229,660 |
| Investing activities | ||
| Purchases of available-for-sale debt securities | (877,772) | (843,190) |
| Proceeds from sales of available-for-sale debt securities | — | 280,402 |
| Proceeds from maturities, redemptions and pay-downs of available-for-sale debt securities | 533,969 | 385,694 |
| Proceeds from maturities, redemptions and pay-downs of held-to-maturity debt securities | 55,181 | 55,555 |
| Sales/(purchases) of equity securities, net | 4,764 | 22,472 |
| Originations of loans held for investment, mortgage finance | (74,373,445) | (71,110,334) |
| Proceeds from pay-offs of loans held for investment, mortgage finance | 74,995,775 | 70,268,104 |
| Decrease/(increase) in loans held for investment, excluding mortgage finance, net | (734,430) | (936,069) |
| Purchase of premises and equipment, net | (10,498) | (12,910) |
| Net cash used in investing activities | (406,456) | (1,890,276) |
| Financing activities | ||
| Net increase/(decrease) in deposits, net | 1,266,888 | 2,266,799 |
| Issuance of stock related to stock-based awards | (9,718) | (7,559) |
| Common stock dividends paid | (17,295) | — |
| Preferred stock dividends paid | (12,938) | (12,938) |
| Repurchase of common stock | (201,718) | (59,234) |
| Net increase/(decrease) in short-term borrowings, net | (330,000) | (610,000) |
| Redemption of long-term debt | (509,525) | (40,435) |
| Issuance of long-term debt | 397,515 | — |
| Net cash provided by financing activities | 583,209 | 1,536,633 |
| Net increase/(decrease) in cash and cash equivalents | 575,041 | (123,983) |
| Cash and cash equivalents at beginning of period | 2,099,118 | 3,188,808 |
| Cash and cash equivalents at end of period | 2,674,159 | 3,064,825 |
| Supplemental disclosures of cash flow information | ||
| Cash paid during the period for interest | 541,377 | 580,591 |
| Cash paid during the period for income taxes | 100,163 | 67,402 |
| Transfers of loans from held for investment to held for sale | 21,333 | — |
Amounts as printed on the EDGAR/iXBRL face — (in thousands except per share data); (in thousands except share data); (in thousands). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗